| 1 |
34992683 | Paclitaxel resistance is mediated by NF-κB on mesenchymal primary breast cancer cells. | 2022 Feb |
1 |
| 2 |
34608124 | Severe cellular stress activates apoptosis independently of p53 in osteosarcoma. | 2021 Oct 4 |
1 |
| 3 |
34903710 | The BH3-only protein NOXA serves as an independent predictor of breast cancer patient survival and defines susceptibility to microtubule targeting agents. | 2021 Dec 13 |
2 |
| 4 |
32401925 | Treatment with β-elemene combined with paclitaxel inhibits growth, migration, and invasion and induces apoptosis of ovarian cancer cells by activation of STAT-NF-κB pathway. | 2020 |
1 |
| 5 |
32505840 | Xiaoaiping injection enhances paclitaxel efficacy in ovarian cancer via pregnane X receptor and its downstream molecules. | 2020 Oct 28 |
1 |
| 6 |
30359947 | MYC-Induced miR-203b-3p and miR-203a-3p Control Bcl-xL Expression and Paclitaxel Sensitivity in Tumor Cells. | 2019 Jan |
1 |
| 7 |
30431082 | ERp57‑small interfering RNA silencing can enhance the sensitivity of drug‑resistant human ovarian cancer cells to paclitaxel. | 2019 Jan |
1 |
| 8 |
31462500 | Pooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian Cancer. | 2019 Nov |
2 |
| 9 |
30013393 | The effect of HIF-1α and PKM1 expression on acquisition of chemoresistance. | 2018 |
1 |
| 10 |
28441715 | Targeting the Bcl-2 family and P-glycoprotein reverses paclitaxel resistance in human esophageal carcinoma cell line. | 2017 Jun |
2 |
| 11 |
28507307 | A Novel Indication for Panobinostat as a Senolytic Drug in NSCLC and HNSCC. | 2017 May 15 |
1 |
| 12 |
28693250 | Bcl-2/Bcl-xL inhibitor ABT-737 sensitizes pancreatic ductal adenocarcinoma to paclitaxel-induced cell death. | 2017 Jul |
3 |
| 13 |
26995790 | Treatment of experimental human breast cancer and lung cancer brain metastases in mice by macitentan, a dual antagonist of endothelin receptors, combined with paclitaxel. | 2016 Apr |
1 |
| 14 |
27779649 | Effect of curcumin and paclitaxel on breast carcinogenesis. | 2016 Dec |
1 |
| 15 |
28620450 | Predicting Outcomes of Hormone and Chemotherapy in the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) Study by Biochemically-inspired Machine Learning. | 2016 |
1 |
| 16 |
25596561 | Mechanism of synergy of BH3 mimetics and paclitaxel in chronic myeloid leukemia cells: Mcl-1 inhibition. | 2015 Apr 5 |
1 |
| 17 |
25811469 | Combining paclitaxel with ABT-263 has a synergistic effect on paclitaxel resistant prostate cancer cells. | 2015 |
6 |
| 18 |
24566868 | RSF1 is a positive regulator of NF-κB-induced gene expression required for ovarian cancer chemoresistance. | 2014 Apr 15 |
1 |
| 19 |
24621501 | Phospho-Bcl-xL(Ser62) influences spindle assembly and chromosome segregation during mitosis. | 2014 |
3 |
| 20 |
23474708 | Inhibition of Hec1 expression enhances the sensitivity of human ovarian cancer cells to paclitaxel. | 2013 Apr |
1 |
| 21 |
23681233 | Hypoxia counteracts taxol-induced apoptosis in MDA-MB-231 breast cancer cells: role of autophagy and JNK activation. | 2013 May 16 |
4 |
| 22 |
23802633 | BCL2 and BCLxL are key determinants of resistance to antitubulin chemotherapeutics in melanoma cells. | 2013 Aug |
2 |
| 23 |
22076480 | Paclitaxel sensitivity of breast cancer cells requires efficient mitotic arrest and disruption of Bcl-xL/Bak interaction. | 2012 Jun |
2 |
| 24 |
22433870 | Tyrosine-phosphorylated caveolin-1 (Tyr-14) increases sensitivity to paclitaxel by inhibiting BCL2 and BCLxL proteins via c-Jun N-terminal kinase (JNK). | 2012 May 18 |
2 |
| 25 |
22965228 | Cyclin-dependent kinase-1 (Cdk1)/cyclin B1 dictates cell fate after mitotic arrest via phosphoregulation of antiapoptotic Bcl-2 proteins. | 2012 Nov 9 |
2 |
| 26 |
21220478 | Navitoclax enhances the efficacy of taxanes in non-small cell lung cancer models. | 2011 Mar 15 |
1 |
| 27 |
21965726 | Paclitaxel and TRAIL synergize to kill paclitaxel-resistant small cell lung cancer cells through a caspase-independent mechanism mediated through AIF. | 2011 Oct |
1 |
| 28 |
20100468 | Synchronised phosphorylation of BNIP3, Bcl-2 and Bcl-xL in response to microtubule-active drugs is JNK-independent and requires a mitotic kinase. | 2010 Jun 1 |
1 |
| 29 |
20100569 | Autotaxin delays apoptosis induced by carboplatin in ovarian cancer cells. | 2010 Jun |
1 |
| 30 |
19351859 | Connective tissue growth factor confers drug resistance in breast cancer through concomitant up-regulation of Bcl-xL and cIAP1. | 2009 Apr 15 |
1 |
| 31 |
19461204 | The role of Bcl-xL and nuclear factor-kappaB in the effect of taxol on the viability of dendritic cells. | 2009 Jun |
2 |
| 32 |
18281549 | Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin. | 2008 Feb 15 |
4 |
| 33 |
18047955 | Optimizing chemotherapy for transitional cell carcinoma by application of bcl-2 and bcl-xL antisense oligodeoxynucleotides. | 2007 Nov-Dec |
1 |
| 34 |
16188300 | Bcl-X(L) is functionally non-equivalent for the regulation of growth and survival in human ovarian cancer cells. | 2006 Feb |
1 |
| 35 |
16231322 | FHIT protein enhances paclitaxel-induced apoptosis in lung cancer cells. | 2006 Apr 1 |
1 |
| 36 |
15661210 | Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent disease. | 2005 Feb |
2 |
| 37 |
16080463 | Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel. | 2005 May-Jun |
8 |
| 38 |
16243823 | Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. | 2005 Oct 15 |
1 |
| 39 |
16275990 | A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells. | 2005 Nov |
2 |
| 40 |
14749477 | Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. | 2004 Jan |
2 |
| 41 |
14975768 | Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells. | 2004 Mar 12 |
4 |
| 42 |
12633850 | Identification of a novel Bcl-xL phosphorylation site regulating the sensitivity of taxol- or 2-methoxyestradiol-induced apoptosis. | 2003 Mar 13 |
3 |
| 43 |
12883037 | Inhibition of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase enhances chemotherapeutic effects on H460 human non-small cell lung cancer cells through activation of apoptosis. | 2003 Jul |
1 |
| 44 |
14617792 | Rituximab (anti-CD20) selectively modifies Bcl-xL and apoptosis protease activating factor-1 (Apaf-1) expression and sensitizes human non-Hodgkin's lymphoma B cell lines to paclitaxel-induced apoptosis. | 2003 Nov |
1 |
| 45 |
26680929 | Differential Sensitivity of Taxol-induced Apoptosis in U2OS and SaOS2 Osteogenic Sarcoma Cells. | 2003 Apr |
1 |
| 46 |
11857368 | Overexpression of BclXL in a human ovarian carcinoma cell line: paradoxic effects on chemosensitivity in vitro versus in vivo. | 2002 Feb 20 |
4 |
| 47 |
12226754 | The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis. | 2002 Sep 19 |
2 |
| 48 |
12389115 | Involvement of mitochondrial pathway in Taxol-induced apoptosis of human T24 bladder cancer cells. | 2002 Oct |
1 |
| 49 |
12452453 | Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamide. | 2002 Nov |
1 |
| 50 |
11592339 | Synergistic interaction between topotecan and microtubule-interfering agents. | 2001 Sep |
2 |